Login / Signup

Therapeutic Bayesian monitoring of sunitinib in two patients with impaired absorption or elimination.

Fanny LeenhardtMarie VialaDiego TosiEmmanuelle Samalin-ScalziAlexandre EvrardLitaty C Mbatchi
Published in: Journal of clinical pharmacy and therapeutics (2021)
Our analysis showed that Bayesian analysis can be successfully applied for real-time TDM to optimize sunitinib blood levels in patients with major comorbidities.
Keyphrases
  • renal cell carcinoma